Myriad Genetics
MYGN
#6699
Rank
ยฃ0.49 B
Marketcap
ยฃ5.32
Share price
-3.27%
Change (1 day)
-58.49%
Change (1 year)

Myriad Genetics (MYGN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ0.26 Billion

According to Myriad Genetics's latest financial reports the company's total liabilities are ยฃ0.26 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ0.26 B-8.76%
2023-12-31ยฃ0.28 B10.26%
2022-12-31ยฃ0.25 B-1.07%
2021-12-31ยฃ0.26 B
2020-06-30ยฃ0.39 B5.19%
2019-06-30ยฃ0.37 B135.66%
2018-06-30ยฃ0.15 B-53.28%
2017-06-30ยฃ0.33 B241.24%
2016-06-30ยฃ99.33 M49.69%
2015-06-30ยฃ66.36 M8.34%
2014-06-30ยฃ61.25 M23.8%
2013-06-30ยฃ49.47 M41.19%
2012-06-30ยฃ35.04 M27.7%
2011-06-30ยฃ27.43 M14.75%
2010-06-30ยฃ23.91 M22.49%
2009-06-30ยฃ19.52 M-47.27%
2008-06-30ยฃ37.02 M110.69%
2007-06-30ยฃ17.57 M19.77%
2006-06-30ยฃ14.67 M11.45%
2005-06-30ยฃ13.16 M58.9%
2004-06-30ยฃ8.28 M-29.37%
2003-06-30ยฃ11.72 M-36.97%
2002-06-30ยฃ18.6 M-19.17%
2001-06-30ยฃ23.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Bio-Rad Laboratories
BIO
ยฃ2.22 B 732.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
ยฃ2.55 B 856.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
ยฃ16.37 M-93.86%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.16 B 338.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ24.70 B 9,164.57%๐Ÿ‡บ๐Ÿ‡ธ USA